This large series of TFE3-RCC and TFEB-RCC provides population data regarding these rare tumors and demonstrates the clinical value of targeted FISH strategies. Our results suggest that GPNMB IHC is ...

Samples were divided into three groups depending on the histological type of cancer: clear cell, papillary and chromophobe RCC. Immunohistochemistry and PCR methods were used to identify WNT10A, Fzd5, ...

TFE3 immunohistochemistry (TFE3-IHC) is controversial in the diagnosis of TFE3-rearranged renal cell carcinoma (TFE3-rearranged RCC). This study is to investigate the accuracy and sensitivity of IHC ...

Real-world, retrospective data showed that morphologic renal cell carcinoma types and tumor-stages helps to inform recurrence and prognosis. Real-world, retrospective data showed that morphologic ...

2. Molecularly-defined RCC subtypes may pose diagnostic challenges, due to morphological variability. Ancillary techniques, including fluorescence in situ hybridisation, immunohistochemistry, and next ...

Patients were excluded if they had received previous systemic anticancer therapy for advanced renal-cell carcinoma ... with the use of the Dako PD-L1 IHC 28-8 pharmDx test. 15 The protocol ...

A higher baseline tumor CD70 immunohistochemistry H-Score was found to correlate ... There remains a high unmet need for patients with relapsed/refractory RCC, as the population has poor survival ...

LINC00493‐derived mitochondrial microprotein SMIM26 suppresses clear cell renal cell carcinoma metastasis via interaction ... Source data are available online for this figure. Representative ...

In this phase 3, randomized, open-label trial, we randomly assigned adults with previously untreated clear-cell, advanced renal-cell carcinoma to ... validated Dako PD-L1 IHC 28-8 pharmDx assay.

In this study, we aimed to review the diagnostic approach to eosinophilic cell renal neoplasms by light microscopy and immunohistochemical techniques. In this study 23 of these tumors were ...